Goat Polyclonal Caveolin-3 antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Pig, Rat samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human CAV3 aa 1-50.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: Tris buffered saline, 0.5% BSA
IHC-P | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Rat | Expected | Tested |
Cow | Predicted | Predicted |
Dog | Predicted | Predicted |
Pig | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 3-5 µg/mL | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Pig, Rat | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Dog | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 0.1-0.3 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Pig | Dilution info 0.1-0.3 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Human | Dilution info 0.1-0.3 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species Rat | Dilution info 0.1-0.3 µg/mL | Notes 1 hour primary incubation is recommended for this product. |
Species | Dilution info | Notes |
---|---|---|
Species Cow, Dog | Dilution info - | Notes - |
Select an associated product type
May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity. May also regulate voltage-gated potassium channels. Plays a role in the sarcolemma repair mechanism of both skeletal muscle and cardiomyocytes that permits rapid resealing of membranes disrupted by mechanical stress (By similarity). Mediates the recruitment of CAVIN2 and CAVIN3 proteins to the caveolae (PubMed:19262564).
Caveolin-3, M-caveolin, CAV3
Goat Polyclonal Caveolin-3 antibody. Suitable for IHC-P, WB and reacts with Human, Mouse, Pig, Rat samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human CAV3 aa 1-50.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: Tris buffered saline, 0.5% BSA
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Caveolin-3 also referred to as 'caveolin' 'caveolae' and 'CAV3' is a protein with an approximate mass of 17 kDa. It acts as a structural component of caveolae small invaginations in the plasma membrane. Caveolin-3 is expressed majorly in muscle cells including cardiac skeletal and smooth muscle tissues. As a distinguishing marker for caveolae it plays an essential role in the formation and stabilization of these structures.
Caveolae perform vital functions in cellular signaling and endocytosis. Caveolin-3 assists in various signaling pathways within muscle cells and interacts with other caveolae markers to facilitate signal transduction. It often forms a complex with other caveolin proteins such as caveolin-1 creating an environment conducive for the embedding of signaling molecules. This protein also modulates the trafficking and function of certain ion channels and receptors impacting muscle physiology.
Caveolin-3 significantly influences pathways concerned with muscle function and signal transduction. In particular it involves itself with the nitric oxide (NO) signaling pathway and beta-adrenergic signaling both critical to the contractile functions of muscle tissues. It closely interacts with proteins such as endothelial nitric oxide synthase (eNOS) and components of the G-protein coupled receptor family indicating its pivotal role in mediating physiological responses to stimuli.
Caveolin-3 mutations have been associated with a range of muscle-related disorders including limb-girdle muscular dystrophy and hypertrophic cardiomyopathy. These conditions often arise due to alterations in muscle cell signaling and integrity. Caveolin-3 also shares connections with proteins like dystrophin an important player in maintaining muscle cell structure and its dysfunction can exacerbate these muscular disorders. Understanding these interactions offers insights into potential therapeutic targets for managing related pathologies.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
Caveolin-3 Western blot staining using goat Anti-Caveolin-3 antibody
Detected by chemiluminescence.
All lanes: Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab87770) at 0.1 µg/mL
Lane 1: pig skeletal muscle tissue lysate at 35 µg
Lane 2: pig heart tissue lysate at 35 µg
Predicted band size: 17 kDa
Observed band size: 20 kDa
Caveolin-3 Western blot staining using goat Anti-Caveolin-3 antibody
Detected by chemiluminescence.
All lanes: Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab87770) at 0.3 µg/mL
Lane 1: mouse heart tissue lysate at 35 µg
Lane 2: rat heart tissue lysate at 35 µg
Predicted band size: 17 kDa
Observed band size: 20 kDa
Caveolin-3 Western blot staining of human heart lysate in RIPA buffer using goat Anti-Caveolin-3 antibody
Detected by chemiluminescence.
All lanes: Western blot - Anti-Caveolin-3 antibody - Caveolae Marker (ab87770) at 0.3 µg/mL
All lanes: human heart lysate in RIPA buffer at 35 µg
Developed using the ECL technique.
Predicted band size: 17 kDa
Observed band size: 23 kDa
Exposure time: 1hr
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com